References
- https://www.who.int/medicines/access/controlled-substances/CannabidiolCriticalReview.pdf
- https://www.fda.gov/consumers/consumer-updates/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis
- Williams D, Stone M, Hauck P, Rahman S. 1989. Why are Secondary Metabolites (Natural Products) Biosynthesized. Journal of Natural Products, 59(6), pp. 1189-1208.
- Goodman, N. 2011. An Overview of the Cannabinoid System. The Vaults of Erowid, v 1.3, https://www.erowid.org/plants/cannabis/cannabis_pharmacology2.shtml.
- Nadal X, del Rio C, Casano S, Palomares B, Ferreiro-Vera C, Navarrette C, Sánchez-Carnerero C, Cantarero I, Bellido, ML, Meyer S, Morello G, Appendino G, Muñoz E. 2017. Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity. British Journal of Pharmacology, 174, pp. 4263-4276.
- Rock EM, Limebeer CL, Parker LA. 2018. Effect of cannabidiolic acid and ∆<sup>9</sup>-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain. Psychopharmacology (Berl).;235(11):3259-3271.
- Izzo, A. A. et al., 2009. Non-psychotropic plant cannabinoids new therapeutic opportunities from an ancient herb. Cell Press, pp. 515-527.
- Bolognini, D., Rock, E. M., Cluny, N. L., Cascio, M. G., Limebeer, C. L., Duncan, M., Stott, C. G., Javid, F. A., Parker, L. A., … Pertwee, R. G. (2013). Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. British journal of pharmacology, 168(6), 1456-70.
- Takeda, S. et. al., 2008. Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis. Drug Metabolism and Disposition, 36 (9), pp. 1917-21.
- Takeda, S. et al., 2014. Cannabidiolic acid had dual inhibitory effects on COX-2 through down-regulation and enzyme inhibition, and may suppress genes that are positively involved in the metastasis of cancer cells in vitro.. J. Toxicol Sci., 39(5), pp. 711-716.
- Takeda, S. et al., 2016. Cannabidiolic acid abrogates the expression of COX-2 via the selective down-regulation of c-fos. J Nat Med..
- a) Takeda, S. et al., 2012. Cannabidiolic acid an active component in the cannabis plant offers potential therapeutic modality in the aborgation of cancer cell migration. Toxicol Let., 214(3), pp. 314-9. b) Takeda, S., Okajima, S., Miyoshi, H., Yoshida, K., Okamoto, Y., Okada, T., Amamoto, T., Watanabe, K., Omiecinski, C. J., … Aramaki, H. (2012). Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration. Toxicology letters, 214(3), 314-9.
- https://chylocure.com/wp-content/uploads/2020/09/Towards-Better-Delivery-of-Cannabidiol-CBD.pdf